Brookfield Asset Management Inc. Novo Nordisk A S Transaction History

Brookfield Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $13.8 Million - $18.3 Million	134,904 New	134,904 $18.3 Million
Q2 2022 Nov 16, 2022	BUY	$103.24 - $121.81 $12.4 Million - $14.7 Million	120,518 New	120,518 $13.4 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $5.95 Million - $7.02 Million	-57,628 Reduced 32.35%	120,518 $13.4 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $11.1 Million - $13.4 Million	119,507 Added 203.8%	178,146 $19.8 Million
Q3 2021 Nov 16, 2021	BUY	$84.42 - $106.62 $2.94 Million - $3.71 Million	34,771 Added 145.68%	58,639 $5.63 Million
Q2 2021 Aug 17, 2021	SELL	$67.66 - $84.76 $1.42 Million - $1.78 Million	-21,012 Reduced 46.82%	23,868 $2 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $3.01 Million - $3.4 Million	44,880 New	44,880 $3.03 Million

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.